Frequency of Gestational Diabetes Mellitus at Collaborating Centers Based on IADPSG Consensus Panel–Recommended Criteria
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To report frequencies of gestational diabetes mellitus (GDM) among the 15 centers that participated in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study using the new International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criteria. RESEARCH DESIGN AND METHODS: All participants underwent a 75-g oral glucose tolerance test between 24 and 32 weeks’ gestation. GDM was retrospectively classified using the IADPSG criteria (one or more fasting, 1-h, or 2-h plasma glucose concentrations equal to or greater than threshold values of 5.1, 10.0, or 8.5 mmol/L, respectively). RESULTS: Overall frequency of GDM was 17.8% (range 9.3–25.5%). There was substantial center-to-center variation in which glucose measures met diagnostic thresholds. CONCLUSIONS: Although the new diagnostic criteria for GDM apply globally, center-to-center differences occur in GDM frequency and relative diagnostic importance of fasting, 1-h, and 2-h glucose levels. This may impact strategies used for the diagnosis of GDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The one-step approach has more than doubled the incidence of GDM, but its clinical benefit in reducing adverse pregnancy outcomes remains controversial.”
From Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications (2022) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This one-step strategy was anticipated to signi fi cantly increase the incidence of GDM (from 5 -6% to 15 -20%), primarily because only one abnormal value, not two, became suf fi cient to make the diagnosis (208).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [208]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This one-step strategy was anticipated to significantly increase the incidence of GDM (from 5-6% to 15-20%), primarily because only one abnormal value, not two, became sufficient to make the diagnosis (191).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [191]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This increase in the number of GDM cases occurred, due to the fact that only one elevated value is required to make the diagnosis [45].”
From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“According to a global observational study, the prevalence of GDM ranged between 9% and 26% in 15 centres51.”
From A global view of hypertensive disorders and diabetes mellitus during pregnancy (2022) · cites this paper as [51]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Self-citationHyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
The HAPO Study Cooperative Research Group (2009) · Diabetes · doi:10.2337/db08-1112 · Cited by 702
Hyperglycemia and Adverse Pregnancy Outcomes: The HAPO Study Cooperative Research Group
(2008) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e318187b7a2 · Cited by 488
Mårdh, P.-A., Paavonen, J. A., & Puolakkainen, M. H. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0719-8_18 · Cited by 26
Cited by
Items 301–400 of 817
Maternal fasting glycemia and adverse pregnancy outcomes in a Mediterranean population
Sesmilo, G., Meler, E., Perea, V., Rodríguez, I., Rodríguez-Melcón, A., Guerrero, M., & Serra, B. (2017) · Acta Diabetologica · doi:10.1007/s00592-016-0952-z · Cited by 23
Cossu, E., Incani, M., Pani, M. G., Gattu, G., Serafini, C., Strazzera, A., Bertoccini, L., Cimini, F. A., Barchetta, I., Cavallo, M. G., et al. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0830-3 · Cited by 23
Weiner, E., Barber, E., Feldstein, O., Schreiber, L., Dekalo, A., Mizrachi, Y., Bar, J., & Kovo, M. (2018) · Placenta · doi:10.1016/j.placenta.2018.01.010 · Cited by 23
Kotzaeridi, G., Blätter, J., Eppel, D., Rosicky, I., Falcone, V., Adamczyk, G., Linder, T., Yerlikaya‐Schatten, G., Weißhaupt, K., Henrich, W., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204794 · Cited by 22
Shashikadze, B., Flenkenthaler, F., Stöckl, J. B., Valla, L., Renner, S., Kemter, E., Wolf, E., & Fröhlich, T. (2021) · Genes · doi:10.3390/genes12121991 · Cited by 22
Nicolosi, B. F., Souza, R. T., Mayrink, J., Feitosa, F. E. D. L., Filho, E. A. R., Leite, D. F. B., Vettorazzi, J., de Sousa, M. H., Costa, M. L., Baker, P. N., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232664 · Cited by 22
Self-citationZhou, X., Li, C., Cheng, H., Xie, J., Li, F., Wang, L., & Ding, R. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-20594-3 · Cited by 22
Jiang, Y., Wei, L., Zhang, H., Chen, Y., Gao, P., Zhang, J., Zhou, X., Zhu, S., Du, Y., Fang, C., et al. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s385774 · Cited by 22
The Role of Hexokinase Domain Containing Protein-1 in Glucose Regulation During Pregnancy
Zapater, J. L., Lednovich, K., & Layden, B. T. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01394-4 · Cited by 21
Huang, P., Deng, Y., Feng, L., Gao, Y., Cheng, X.-Q., & Liu, H. (2022) · Journal of Ultrasound in Medicine · doi:10.1002/jum.15994 · Cited by 21
Epidemiology of Diabetes in Pregnancy
Simmons, D. S. (2017) · Wiley eBooks · doi:10.1002/9781119043805.ch1 · Cited by 21
Schellong, K., Melchior, K., Ziska, T., Henrich, W., Rancourt, R. C., & Plagemann, A. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.108257 · Cited by 21
Dickson, L. M., Buchmann, E., van Rensburg, C. J., & Norris, S. A. (2019) · South African Medical Journal · doi:10.7196/samj.2019.v110i1.14089 · Cited by 21
Liu, J., Song, G., Zhao, G., & Meng, T. (2020) · Bioscience Reports · doi:10.1042/bsr20200990 · Cited by 21
Vidakovic, A. J., Jaddoe, V. W. V., Voortman, T., Demmelmair, H., Koletzko, B. V., & Gaillard, R. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.10.001 · Cited by 21
Mai, C., Wang, B., Wen, J., Lin, X., & Niu, J. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2013.871522 · Cited by 21
“5% according to the Hyperglycemia and Adverse Pregnancy Outcome Study (HAPO) [1].”
MethodInfluentialImpact of different glycaemic treatment targets on pregnancy outcomes in gestational diabetes
Abell, S. K., Boyle, J. A., Earnest, A., England, P., Nankervis, A., Ranasinha, S., Soldatos, G., Wallace, E. M., Zoungas, S., & J Teede, H. (2019) · Diabetic Medicine · doi:10.1111/dme.13799 · Cited by 20
Louwagie, E. J., Larsen, T. D., Wachal, A. L., Gandy, T. C. T., Eclov, J. A., Rideout, T. C., Kern, K. A., Cain, J. T., Anderson, R. H., Mdaki, K. S., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101746 · Cited by 20
Gestational Diabetes Mellitus: New Thinking on Diagnostic Criteria
Luo, J., Tong, L., Xu, A., He, Y., Huang, H., Qiu, D., Guo, X., Chen, H., Xu, L., Li, Y., et al. (2024) · Life · doi:10.3390/life14121665 · Cited by 20
“In a study by Sacks et al. [36], part of the HAPO Study, the prevalence of GDM across 15 centers using the IADPSG criteria ranged from 9.3% to 25.5%, with an overall prevalence of 17.8%.”
InfluentialTierney, M., O’Dea, A., Danyliv, A., Glynn, L. G., McGuire, B. E., Carmody, L. A., Newell, J., & Dunne, F. (2015) · Diabetologia · doi:10.1007/s00125-015-3713-6 · Cited by 20
Dickson, L. M., Buchmann, E., van Rensburg, C. J., & Norris, S. A. (2018) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2018.12.003 · Cited by 20
Nicolosi, B. F., Vernini, J. M., Costa, R., Magalhães, C. G., Rudge, M. V. C., Corrente, J. E., Cecatti, J. G., & Calderon, I. D. M. P. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00556-w · Cited by 20
Schellong, K., Melchior, K., Ziska, T., Rancourt, R. C., Henrich, W., & Plagemann, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17124229 · Cited by 20
Zhou, Q., Wen, S. W., Liu, M., Zhang, S., Jin, X., & Liu, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18010205 · Cited by 20
Verma, N., Srodulski, S. J., Velmurugan, S., Hoskins, A., Pandey, V. K., Despa, F., & Despa, S. I. (2021) · Scientific Reports · doi:10.1038/s41598-021-00422-3 · Cited by 20
Oğlak, S. C., Yavuz, A., Ölmez, F., Özköse, Z. G., & Çaypınar, S. S. (2022) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2022.2083495 · Cited by 20
“5%, depending on the ethnicity, socioeconomic status of the individuals and the screening method used [2].”
MethodAgarwal, M., Punnose, J., Sukhija, K., Sharma, A., & Choudhary, N. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.12.009 · Cited by 20
O’Malley, E. G., Reynolds, C. M. E., O’Kelly, R., McMahon, L. E., Sheehan, S. R., & Turner, M. J. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108144 · Cited by 19
Jorquera, G., Fornes, R., Cruz, G., & Thomas‐Valdés, S. (2022) · Antioxidants · doi:10.3390/antiox11112294 · Cited by 18
Hocaoğlu, M., Turgut, A., Guzin, K., Yardimci, O. D., Gunay, T., Bor, E. D., Akdeniz, E., & Karateke, A. (2018) · Northern Clinics of Istanbul · doi:10.14744/nci.2018.37167 · Cited by 18
“the “hyperglycemia and adverse pregnancy outcome” subjects [14].”
BackgroundLiu, Y., Geng, H. Z., Duan, B., Yang, X., Ma, A., & Ding, X. (2021) · BioMed Research International · doi:10.1155/2021/1984690 · Cited by 18
“Gestational diabetes mellitus (GDM) is one of the most prevalent pregnancy complications, with incidence estimates varying from 2% to 25% depending on the diagnostic criteria used and the population measured [2, 3].”
BackgroundFirst Trimester Screening for Gestational Diabetes Mellitus with Maternal Factors and Biomarkers
Shen, L., Sahota, D. S., Chaemsaithong, P., Tse, W. T., Chung, M. Y., Ip, J. K. H., Leung, T. Y., & Poon, L. C. (2022) · Fetal Diagnosis and Therapy · doi:10.1159/000525384 · Cited by 18
Hernandez, T. L., & Rozance, P. J. (2022) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2022.09.005 · Cited by 18
Comparison of Birth Outcomes by Gestational Diabetes Screening Criteria
Davis, E. M., Scifres, C., Abebe, K. Z., Costacou, T., COMER, D. M., Catalano, P. M., Simhan, H. N., Freiberg, M. S., & Day, N. L. (2018) · American Journal of Perinatology Reports · doi:10.1055/s-0038-1675343 · Cited by 18
Song, D., Lia, M., & Hurley, J. C. (2019) · Diabetic Medicine · doi:10.1111/dme.14073 · Cited by 18
El-Shazly, A. M., Awad, S. E., Abdel-Tawab, A. H., Haridy, F. M., & Morsy, T. A. (2007) · PubMed · Cited by 18
How should we screen for gestational diabetes?
Petrović, O. (2014) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000049 · Cited by 18
Metzger, B. E., & Dyer, A. R. (2014) · Diabetes Care · doi:10.2337/dc13-2526 · Cited by 18
Self-citationYew, T. W., Khoo, C. M., Thai, A. C., Kale, A. S., Yong, E. L., & Tai, E. S. (2014) · Endocrine Practice · doi:10.4158/ep14028.or · Cited by 17
Gut microbiome interacts with pregnancy hormone metabolites in gestational diabetes mellitus
Lyu, X., Wang, S., Zhong, J., Cai, L., Zheng, Y., Zhou, Y., Zhou, Y., Chen, Q., & Li, Q. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1175065 · Cited by 17
Novel therapies for diabetes mellitus in pregnancy
Feghali, M. N., & Scifres, C. (2018) · BMJ · doi:10.1136/bmj.k2034 · Cited by 17
Maternal Early‐Pregnancy Glucose Concentrations and Liver Fat Among School‐Age Children
Geurtsen, M. L., Wahab, R. J., Felix, J. F., Gaillard, R., & Jaddoe, V. W. V. (2021) · Hepatology · doi:10.1002/hep.31910 · Cited by 17
The role of ncRNA regulatory mechanisms in diseases—case on gestational diabetes
Gao, D., Ren, L., Hao, Y.-D., Schaduangrat, N., Liu, X., Yuan, S.-S., Yang, Y. R., Wang, Y., Shoombuatong, W., & Ding, H. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad489 · Cited by 17
First-Trimester Placental Growth Factor in Screening for Gestational Diabetes
Mosimann, B., Amylidi, S., Risch, L., Wiedemann, U., Surbek, D., Baumann, M., Stettler, C., & Raio, L. (2015) · Fetal Diagnosis and Therapy · doi:10.1159/000441027 · Cited by 17
Alves, J., Stollmeier, A., Leite, I., Pilger, C., Detsch, J. M., Radominski, R. B., & Rea, R. R. (2016) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0036-1588008 · Cited by 17
Silva, C., Nunes, C., Correia‐Branco, A., Araújo, J. R., & Martel, F. (2016) · Reproductive Sciences · doi:10.1177/1933719116667220 · Cited by 17
Codina, M., Corcoy, R., Goya, M., Delgado, D. A., Pérez, M. B., Nivela, M. O. B., Rasero, J. L. B., Alfonso, J. B., Blanco‐Carnero, J. E., López, M. A. B., et al. (2020) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2020.05.002 · Cited by 17
McIntyre, H. D., Oats, J. J. N., Kihara, A. B., Divakar, H., Kapur, A., Poon, L. C., & Hod, M. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13764 · Cited by 16
Self-citationWu, Q., Chen, Y., Ma, H., Zhou, T., Hu, Y., Liang, Z., & Chen, D. (2023) · Nutrition & Diabetes · doi:10.1038/s41387-023-00239-1 · Cited by 16
“The IADPSG-HAPO study reported that there was a 30% and 60% increased odds ratio for LGA and SGA in women with GDM [34], whose difference might be greatly related to GWG.”
Options for screening for gestational diabetes mellitus during the SARS‐CoV‐2 pandemic
Simmons, D., Rudland, V. L., Wong, V., Flack, J., Mackie, A., Ross, G. P., Coat, S., Dalal, R., Hague, B. M., & Cheung, N. W. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13224 · Cited by 16
Insulin Management for Gestational and Type 2 Diabetes in Pregnancy
Valent, A. M., & Barbour, L. A. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005640 · Cited by 16
“23,24 Elevated glycemia in the early morning can result in overall higher glycemia across the day with “ borderline ” postprandial glucoses often driven by higher fasting glycemia.”
Biochemical Markers in the Prediction of Pregnancy Outcome in Gestational Diabetes Mellitus
Mandić, V., Dobrijević, Z., Robajac, D., Miljuš, G., Šunderić, M., Penezić, A., Nedić, O., Ardalić, D., Miković, Ž., Radojičić, O., et al. (2024) · Medicina · doi:10.3390/medicina60081250 · Cited by 16
“Incidence of GDM depends on diagnostic criteria and varies by the region, ranging from 9 to − 25%, with a global incidence of 14% [2,3].”
BackgrounddʼEmden, M. C. (2014) · The Medical Journal of Australia · doi:10.5694/mja14.00277 · Cited by 16
Glucose intolerance in the third trimester is not predictive of adverse outcomes
Fonseca, A., Lopes, J. M., & Clode, N. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12923 · Cited by 16
Bogdanet, D., O’Shea, P. M., Halperin, J. A., & Dunne, F. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-03090-9 · Cited by 16
Lim, S. S., Chen, M., Makama, M., & O'Reilly, S. L. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0040-1722315 · Cited by 16
Florian, A. R., Cruciat, G., Pop, R. M., Staicu, A., Daniel, M., & Stamatian, F. V. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9951 · Cited by 16
Phoswa, W. N. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.613930 · Cited by 16
“Womenwith a previous history of GDMhave increased risk of developing T2DM at an earlier stage in life and cardiovascular diseases (32).”
BackgroundKang, S., Kim, M. H., Kim, M. Y., Hong, J., Lim, S. K., Choi, S. H., Lim, S., Park, K. S., & Jang, H. C. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0159 · Cited by 16
Drugs to Control Diabetes During Pregnancy
Feghali, M. N., Umans, J. G., & Catalano, P. M. (2019) · Clinics in Perinatology · doi:10.1016/j.clp.2019.02.005 · Cited by 16
Weight Change and Cardiometabolic Outcomes in Postpartum Women with History of Gestational Diabetes
Lim, S. S., Versace, V. L., O'Reilly, S. L., Janus, E. D., & Dunbar, J. (2019) · Nutrients · doi:10.3390/nu11040922 · Cited by 16
“Gestational diabetes mellitus (GDM) affects one in five pregnancies according to the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criteria [1].”
BackgroundDoyon, M., Pelland-St-Pierre, L., Allard, C., Bouchard, L., Perron, P., & Hivert, M. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.07.008 · Cited by 16
Zhao, H., Li, H., Zheng, Y., Zhu, L., Fang, J., Xiang, L., Xu, S., Zhou, Y. R., Luan, H., Xia, W., et al. (2019) · Science China Chemistry · doi:10.1007/s11426-019-9580-2 · Cited by 16
Babaniamansour, S., Aliniagerdroudbari, E., Afrakhteh, M., Hosseinpanah, F., Farzaneh, F., & Niroomand, M. (2021) · Diabetology International · doi:10.1007/s13340-020-00484-0 · Cited by 16
Li, K., Li, X., Morse, A. N., Fan, J., Yang, C., Gu, C., & Liu, H. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101320 · Cited by 16
Dreisbach, C., Prescott, S. M., Alhusen, J. L., Dudley, D., Trinchieri, G., & Siega‐Riz, A. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271261 · Cited by 16
“Even 11 years later, women with only one abnormal glucose value had a higher risk of developing of type two diabetes mellitus and the complications associated with it [42].”
BackgroundOğlak, S. C., Yılmaz, E. Z., & Budak, M. Ş. (2024) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2024.2329880 · Cited by 15
Jeffery, T., Petersen, R. W., & Quinlivan, J. A. (2016) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12487 · Cited by 15
Reyes-Muñoz, E., Sandoval-Osuna, N. L., Reyes-Mayoral, C., Ortega-González, C., Martínez-Cruz, N., Ramírez-Torres, M. A., Arce-Sánchez, L., Lira-Plascencia, J., Estrada‐Gutiérrez, G., & Montoya-Estrada, A. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021617 · Cited by 15
Yerlikaya‐Schatten, G., Falcone, V., Linder, T., Mittlböck, M., Tura, A., Husslein, P. W., Eppel, W., & Göbl, C. S. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3243754 · Cited by 15
“However, it was found that these recommendations resulted in a markedly increased number of GDM cases [3] containing a heterogenic group of pregnant women on the wide range of disturbed glucose metabolism.”
BackgroundRuiz-Hoyos, B. M., Franco, Á. L. L., & Ramírez-Aristizábal, R. A. (2018) · Revista Colombiana de Obstetricia y Ginecología · doi:10.18597/rcog.3056 · Cited by 15
Prepubertal Children Exposed to Maternal Gestational Diabetes Have Latent Low-Grade Inflammation
Antikainen, L., Jääskeläinen, J., Nordman, H., Voutilainen, R., & Huopio, H. (2018) · Hormone Research in Paediatrics · doi:10.1159/000491938 · Cited by 15
The association between second trimester ultrasound fetal biometrics and gestational diabetes
Andersen, A. S., Rathcke, S. L., Christensen, T. T., & Sørensen, A. (2022) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2022.07.015 · Cited by 14
Intermediate hyperglycemia in early pregnancy: A South Asian perspective
Punnose, J., Sukhija, K., & Rijhwani, R. M. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.573 · Cited by 14
Cronin, Á., Noctor, E., O’Doherty, D., Bowers, S., Byrne, E., & Cremona, A. (2023) · Public Health · doi:10.1016/j.puhe.2023.04.022 · Cited by 14
Bline, A. P., Ellis, L. B., Pelch, K. E., Lam, J., Sen, Ś., Zlatnik, M. G., & Varshavsky, J. (2024) · Environment International · doi:10.1016/j.envint.2024.108711 · Cited by 14
Oğlak, S. C., Aşir, F., Yılmaz, E. Z., Bolluk, G., Korak, T., & Ağaçayak, E. (2024) · Zeitschrift für Geburtshilfe und Neonatologie · doi:10.1055/a-2451-2223 · Cited by 14
Cosson, E., Valensi, P. E., & Carbillon, L. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.08.001 · Cited by 14
de Langarica, A. G. G., Hediger, H., Kaeppeli, B. M., & Keller‐Senn, A. (2022) · Midwifery · doi:10.1016/j.midw.2022.103367 · Cited by 14
Defining gestational diabetes: not just about cutoffs
Simmons, D. S., & Sweeting, A. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00092-x · Cited by 14
Sibartie, P., & Quinlivan, J. A. (2015) · Journal of Pregnancy · doi:10.1155/2015/754085 · Cited by 14
“5% contrasts higher background rates in the sites involved in the HAPO trial where incidences ranged from 8 to 25% [12].”
BackgroundMaternal serum screening marker levels in twin pregnancies affected by gestational diabetes
Maymon, R., Meiri, H., Svirsky, R., Weiner, E., & Cuckle, H. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-5010-3 · Cited by 14
O'Reilly, S. L., Versace, V. L., Mohebbi, M., Lim, S. S., Janus, E. D., & Dunbar, J. (2019) · BMC Women s Health · doi:10.1186/s12905-019-0788-0 · Cited by 14
Chen, Y., Liu, H., Wang, L., Zhou, T., Liang, Z., Li, W., Shang, X., Leng, J., Shen, Y., Hu, G., et al. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz121 · Cited by 14
Niroomand, M., Afsar, J., Hosseinpanah, F., Afrakhteh, M., Farzaneh, F., & Serahati, S. (2019) · Intern J Endocrinol Metab · doi:10.5812/ijem.88343 · Cited by 14
Rancourt, R. C., Ott, R., Schellong, K., Melchior, K., Ziska, T., Henrich, W., & Plagemann, A. (2019) · Adipocyte · doi:10.1080/21623945.2019.1675239 · Cited by 14
Coetzee, A., Sadhai, N., Mason, D., Hall, D. R., & Conradie, M. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108421 · Cited by 14
“The HAPO trial demonstrated that glucose levels previously considered normal in pregnancy do confer maternal and fetal risks, and that the degree of hyperglycemia correlates with risk [11].”
BackgroundScazzocchio, B., Filardi, T., Varí, R., Brunelli, R., Galoppi, P., Morano, S., Masella, R., & Santangelo, C. (2021) · Food & Function · doi:10.1039/d1fo00267h · Cited by 14
Beta-Cell ARNT Is Required for Normal Glucose Tolerance in Murine Pregnancy
Lau, S. M., Cha, K. M., Karunatillake, A., Stokes, R., Cheng, K., McLean, M. P., Cheung, N. W., Gonzalez, F. J., & Gunton, J. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077419 · Cited by 14
“Inability to increase beta-cell function in order to match the metabolic demands of pregnancy results in GDM [6,7].”
InfluentialHannon, T. S., Carroll, A. E., Palmer, K. N. B., Saha, C., Childers, W. K., & Marrero, D. G. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.11.016 · Cited by 14
Gestational Diabetes Mellitus Update and Review of Literature
Cheung, K. W., & Wong, S.-N. (2018) · Reproductive System & Sexual Disorders · doi:10.4172/2161-038x.s2-008 · Cited by 14
“Since the relative diagnostic accuracies of fasting, 1-h, and 2-h glucose levels were different in different centers, some authors proposed the screening strategy could be modified according to the respective diagnostic values in different centers to improve its cost effectiveness [33, 45].”
BackgroundGestational microbiome: metabolic perturbations and developmental programming
Han, S., Ellberg, C. C., Olomu, I. N., & Vyas, A. K. (2021) · Reproduction · doi:10.1530/rep-21-0241 · Cited by 13
Sugawara, D., Sato, H., Makita, E., Kuwata, T., Takagi, K., & Ichihashi, K. (2022) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2021.10.007 · Cited by 13
Chatzakis, C., Koletsos, N., Tirta, M., Dinas, K. D., Gkaliagkousi, Ε., & Sotiriadis, A. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3600 · Cited by 13
Pu, Y., Liu, Q., Hu, K., Liu, X., Bai, H., Wu, Y., Zhou, M., & Fan, P. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05742-y · Cited by 13
“For all subjects, a two-way univariate general linear model introducing both the genotypes and GDM status as independent variables, with age and pre-pregnancy BMI as covariates was performed.”
BackgroundInfluentialScreening for gestational diabetes in the Lombardy region: A population-based study
Nicotra, F., Molinari, C., Dozio, N., Castiglioni, M. T., Ibrahim, B., Zambon, A., Corrao, G., & Scavini, M. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.11.008 · Cited by 13
Pouliot, A., Elmahboubi, R., & Adam, C. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.10.003 · Cited by 13
Souza, C. M., & Iser, B. P. M. (2022) · Midwifery · doi:10.1016/j.midw.2022.103428 · Cited by 13
Lower treatment targets for gestational diabetes: is lower really better?
Kevat, D., Sinha, A. K., & McLean, A. (2014) · The Medical Journal of Australia · doi:10.5694/mja14.00099 · Cited by 13
Gao, Q., He, G., Zhang, L., Bai, H., Liu, X., & Fan, P. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2782 · Cited by 13
Metadata
- Authors
- Sacks, D. A., Hadden, D. R., Maresh, M., Deerochanawong, C., Dyer, A. R., Metzger, B. E., Lowe, L. P., Coustan, D. R., Hod, M., Oats, J. J. N., Persson, B., Trimble, E. R., & for the HAPO Study Cooperative Research Group
- Affiliations
- Kaiser Foundation Hospital (US)
- Royal Victoria Hospital (GB)
- St Mary's Hospital (GB)
- Rajavithi Hospital (TH)
- Northwestern University (US)
- Brown University (US)
- Tel Aviv University (IL)
- The University of Queensland (AU)
- Karolinska Institutet (SE)
- Queen's University Belfast (GB)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-02-10
- Volume
- 35
- Issue
- 3
- Pages
- 526-528
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3322716
- OpenAlex
- W2114819974
- Cited by
- 687
- References
- 6
- Citations by year
- 2026: 24 · 2025: 33 · 2024: 39 · 2023: 41 · 2022: 77 · 2021: 57 · 2020: 65 · 2019: 56 · 2018: 65 · 2017: 38 · 2016: 47 · 2015: 42 · 2014: 54 · 2013: 24 · 2012: 21
- FWCI
- 54.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Funders
- American Diabetes Association
- Kaiser Permanente
- Diabetes UK (RD04/ 0002756)
- Novo Nordisk
- National Institute of Diabetes and Digestive and Kidney Diseases (R01‐HD34243, R01-HD34242)
- National Institute of Child Health and Human Development (R01‐HD34242, R01-HD-34243)
- National Center for Research Resources (M01RR000080, M01 RR00048, M01RR00080, M01RR000048)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD-34242, 01-HD34243, R01HD034242, R01HD034243)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- gestational diabetes mellitus, IADPSG criteria, GDM prevalence, oral glucose tolerance test, diagnostic thresholds, HAPO study, fasting blood glucose, 2-hour plasma glucose
- MeSH terms
- Adult, Blood Glucose, Female, Glucose Tolerance Test, Humans, Hyperglycemia, Pregnancy, Diabetes, Gestational, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.